IN Brief:
- The 3,505 sq m HealthChain-certified centre is located at Frankfurt Airport's Cargo City South.
- It provides around 2,500 sq m at 15°C–25°C, more than 500 sq m at 2°C–8°C, and storage down to -70°C.
- Direct tarmac access links the facility with Kuehne+Nagel's expanding healthcare air-freight network through Frankfurt.
Kuehne+Nagel has opened a 3,505 sq m healthcare logistics centre at Frankfurt Airport, adding dedicated controlled-temperature capacity for pharmaceutical and healthcare cargo moving through one of Europe’s largest air-freight gateways.
The HealthChain-certified facility is located in Cargo City South within a 13,000 sq m complex owned by Kuehne+Nagel. Direct tarmac access provides rapid connections with airport cargo handling areas, reducing the distance and number of transfers between controlled storage, road transport, and aircraft.
Approximately 2,500 sq m is allocated to controlled-room-temperature products held between 15°C and 25°C, while more than 500 sq m is reserved for cold-chain cargo requiring 2°C to 8°C. Ultra-low-temperature freezers extend the operating range to products requiring storage at -70°C.
The centre also contains temperature-controlled staging areas and specialist pharmaceutical truck-handling facilities. It operates within a Good Distribution Practice environment and joins Kuehne+Nagel’s network of more than 270 HealthChain-certified locations.
Frankfurt has taken on a larger role in the company’s healthcare network during 2026. The airport was added to Kuehne+Nagel’s Inspire Boeing 747-8F freighter programme earlier in the year, while a Frankfurt–Atlanta Cool Corridor was introduced for temperature-sensitive healthcare cargo.
The new centre places specialist storage and staging infrastructure alongside those air services. Temperature control during flight is only one part of a pharmaceutical movement; products can also spend significant periods waiting during unloading, security processing, customs activity, staging, rebooking, and transfer into onward road transport.
Direct tarmac access reduces some of that exposed movement. Shortening the physical transfer between cargo handling and controlled storage gives operators more time inside validated packaging limits and lowers the number of intermediate handling points at which products may leave their specified temperature range.
The different storage zones reflect the range of pharmaceutical products moving by air. Many medicines and ingredients can travel under controlled room temperature conditions, while vaccines, biologics, and other sensitive products may require refrigerated handling. Advanced therapies, clinical materials, and some specialist products can require frozen or ultra-low-temperature storage.
Those categories cannot simply be placed into one generic refrigerated warehouse. Each temperature range creates its own monitoring, equipment, packaging, alarm, and handling requirements, particularly where a shipment is delayed and has to remain at the airport longer than expected.
Martin Schaefer, SVP Air Logistics Germany at Kuehne+Nagel, said the new centre provides customers with “greater reliability, connectivity, and control across global supply chains”.
The infrastructure behind that claim is specific: controlled temperature zones, direct airside access, pharmaceutical truck handling, staging capacity, and integration into an existing certified network. Those elements become particularly valuable when transport plans change, because delayed healthcare cargo cannot simply be placed into ordinary airport storage while an alternative flight is found.
Kuehne+Nagel has been adding corridor capacity elsewhere at the same time. Its healthcare network has expanded routes linking Frankfurt with Atlanta, Chicago with Narita, Brussels with São Paulo, and Chicago with São Paulo, establishing defined processes for temperature-sensitive cargo across major pharmaceutical markets.
Frankfurt provides a natural European node for that activity. Germany combines a substantial pharmaceutical manufacturing base with long-haul air connectivity, while the airport’s cargo infrastructure supports both passenger belly capacity and dedicated freighter operations.
The economics of healthcare logistics also differ from general cargo. A pharmaceutical consignment may occupy relatively little space while carrying a value far above its physical weight, making air freight commercially viable where speed and product integrity dominate transport cost.
A temperature excursion can nevertheless destroy that value without any visible damage to the outer packaging. The less obvious stages of the journey — temporary storage, waiting areas, handovers, and exception management — therefore carry the same quality requirements as the aircraft or refrigerated truck.
That makes staging capacity particularly important. Cargo arriving before its onward connection, or missing a planned movement because of disruption, needs somewhere validated to wait. A warehouse close to the apron can absorb those schedule changes without immediately forcing the shipment into a less controlled environment.
Visibility provides another layer of control, but temperature data does not correct an excursion after it has occurred. Monitoring is most valuable when operations can respond quickly enough to move the shipment, replace packaging, arrange alternative capacity, or intervene before remaining thermal protection is exhausted.
The Frankfurt centre therefore expands more than Kuehne+Nagel’s nominal warehouse footprint. It adds specialist capacity at the transfer point between aircraft, storage, and road transport, where several of the highest-risk handovers in an international pharmaceutical shipment occur.
Its performance will be measured in the routine details: how quickly cargo moves from aircraft to controlled storage, whether required temperatures remain stable during disruption, and how reliably the facility connects with the wider HealthChain network. Those are less visible than another freighter route, but they determine whether temperature-sensitive products arrive usable at the end of it.
